Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study

JACC: Cardiovascular Imaging

Volumn 4, Issue 11, 2011, Pages 1195-1205

  Bucerius, Jan ^a,b   Duivenvoorden, Raphal ^a,c   Mani, Venkatesh ^a   Moncrieff, Colin ^a   Rudd, James H F ^d   Calcagno, Claudia ^a   MacHac, Josef ^a   Fuster, Valentin ^a,e   Farkouh, Michael E ^a   Fayad, Zahi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BONN   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

atherosclerosis; FDG PET; inflammation; metabolic syndrome; obesity

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTERY WALL; ARTICLE; BODY MASS; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIPLE LINEAR REGRESSION ANALYSIS; OBESITY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SMOKING; VASCULITIS;

AGED; ANALYSIS OF VARIANCE; CAROTID ARTERY DISEASES; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; LINEAR MODELS; MALE; MIDDLE AGED; NEW YORK CITY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREVALENCE; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS;

EID: 81255162884     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2011.07.008     Document Type: Article

References (40)

1. P. Libby, P.M. Ridker, and G.K. Hansson Inflammation in atherosclerosis: from pathophysiology to practice J Am Coll Cardiol 54 2009 2129 2138
2. S.M. Grundy, J.I. Cleeman, C.N. Merz Coordinating Committee of the National Cholesterol Education Program Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines J Am Coll Cardiol 44 2004 720 732
3. P. Libby The forgotten majority: unfinished business in cardiovascular risk reduction J Am Coll Cardiol 46 2005 1225 1228 (Pubitemid 41615541)
4. C.L. Heslop, J.J. Frohlich, and J.S. Hill Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography J Am Coll Cardiol 55 2010 1102 1109
5. P.M. Ridker, E. Danielson, F.A. Fonseca JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
6. P. Libby, P.M. Ridker, G.K. Hansson Leducq Transatlantic Network on Atherothrombosis Inflammation in atherosclerosis: from pathophysiology to practice J Am Coll Cardiol 54 2009 2129 2138
7. A. Tawakol, R.Q. Migrino, and G.G. Bashian In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 2006 1818 1824 (Pubitemid 44648622)
8. J.H. Rudd, E.A. Warburton, and T.D. Fryer Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography Circulation 105 2002 2708 2711 (Pubitemid 34615139)
9. S.F. Pedersen, M. Graebe, A.M. Fisker Hag, L. Højgaard, H. Sillesen, and A. Kjaer Gene expression and 18FDG uptake in atherosclerotic carotid plaques Nucl Med Commun 31 2010 423 429
10. N. Tahara, H. Kai, and M. Ishibashi Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography J Am Coll Cardiol 48 2006 1825 1831 (Pubitemid 44648621)
11. S.J. Lee, Y.K. On, E.J. Lee, J.Y. Choi, B.T. Kim, and K.H. Lee Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction J Nucl Med 49 2008 1277 1282
12. N. Tahara, H. Kai, and S. Yamagishi Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome J Am Coll Cardiol 49 2007 1533 1539 (Pubitemid 46517964)
13. J.H. Rudd, K.S. Myers, and S. Bansilal Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study Circ Cardiovasc Imaging 2 2009 107 115
14. J.H. Rudd, K.S. Myers, and S. Bansilal (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials J Am Coll Cardiol 50 2007 892 896 (Pubitemid 47268746)
15. P.E. Kinahan, and J.G. Rogers Analytic 3D image reconstruction using all detected events IEEE Trans Nucl Sci 36 1989 964 968
16. L.K. Shankar, J.M. Hoffman, S. Bacharach National Cancer Institute Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials J Nucl Med 47 2006 1059 1066 (Pubitemid 46939960)
17. A. Tawakol, R.Q. Migrino, and U. Hoffmann Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography J Nucl Cardiol 12 2005 294 301 (Pubitemid 40790404)
18. M. Eliasziw, S.L. Young, M.G. Woodbury, and K. Fryday-Field Statistical methodology for the concurrent assessment of interrater and intrarater reliability: using goniometric measurements as an example Phys Ther 74 1994 777 788 (Pubitemid 24245119)
19. A.C. van der Wal, A.E. Becker, C.M. van der Loos, and P.K. Das Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology Circulation 89 1994 36 44 (Pubitemid 24026469)
20. The HRP Initiative The HRP website http://www.hrpinitiative.com Accessed June 3, 2011
21. H. Schumacher, E. Kaiser, P.A. Schnabel, J. Sykora, H.H. Eckstein, and J.R. Allenberg Immunophenotypic characterisation of carotid plaque: increased amount of inflammatory cells as an independent predictor for ischaemic symptoms Eur J Vasc Endovasc Surg 21 2001 494 501 (Pubitemid 32624582)
22. S. Jander, M. Sitzer, and R. Schumann Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization Stroke 29 1998 1625 1630 (Pubitemid 28365585)
23. S.C. Carr, A. Farb, W.H. Pearce, R. Virmani, and J.S. Yao Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis Surgery 122 1997 757 763
24. S.I. van Leuven, D.F. van Wijk, and O.L. Volger Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis Atherosclerosis 211 2010 231 236
25. D.F. van Wijk, E.S. Stroes, and G.M. Dallinga-Thie Novel insights into anti-inflammatory actions of HDL Atherosclerosis 212 2010 388 389
26. E.A. Stein, E.S. Stroes, and G. Steiner Safety and tolerability of dalcetrapib Am J Cardiol 104 2009 82 91
27. R. Duivenvoorden, E. de Groot, E.S. Stroes, and J.J. Kastelein Surrogate markers in clinical trialschallenges and opportunities Atherosclerosis 206 2009 8 16
28. J.H. Rudd, J. Narula, and H.W. Strauss Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol 55 2010 2527 2535
29. K.G. Alberti, P. Zimmet, J. Shaw IDF Epidemiology Task Force Consensus Group The metabolic syndrome: a new worldwide definition Lancet 366 2005 1059 1062 (Pubitemid 41338752)
30. A.S. Gami, B.J. Witt, and D.E. Howard Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies J Am Coll Cardiol 49 2007 403 414 (Pubitemid 46135879)
31. L.F. Van Gaal, I.L. Mertens, and C.E. De Block Mechanisms linking obesity with cardiovascular disease Nature 444 2006 875 880 (Pubitemid 46028447)
32. V.Z. Rocha, and P. Libby Obesity, inflammation, and atherosclerosis Nat Rev Cardiol 6 2009 399 409
33. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91 (Pubitemid 23036092)
34. T.N. Kim, S. Kim, and S.J. Yang Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography Circ Cardiovasc Imaging 3 2010 142 148
35. N. Ouchi, and K. Walsh Adiponectin as an anti-inflammatory factor Clin Chim Acta 380 2007 24 30 (Pubitemid 46498041)
36. M. Komatsu, H. Ohfusa, T. Aizawa, and K. Hashizume Adiponectin inversely correlates with high sensitive c-reactive protein and triglycerides, but not with insulin sensitivity, in apparently healthy Japanese men Endocr J 54 2007 553 558 (Pubitemid 47414602)
37. H.J. Yoo, S.E. Kim, and M.S. Park Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with 18F-fluorodeoxyglucose positron emission tomography J Clin Endocrinol Metab 96 2011 E488 E492
38. B.V. Howard, G. Ruotolo, and D.C. Robbins Obesity and dyslipidemia Endocrinol Metab Clin N Am 32 2003 855 867 (Pubitemid 38029984)
39. B. Paulmier, M. Duet, and R. Khayat Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events J Nucl Cardiol 15 2008 209 217 (Pubitemid 351396317)
40. A. Rominger, T. Saam, and S. Wolpers 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease J Nucl Med 50 2009 1611 1620